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Prediction of Hypertension Improvement
After Stenting of Renal Artery Stenosis
Comparative Accuracy of Translesional Pressure
Gradients, Intravascular Ultrasound, and Angiography
Massoud A. Leesar, MD,* Jai Varma, MD,* Adam Shapira, MD,* Ibrahim Fahsah, MD,*
Seyed T. Raza, MD,† Ziad Elghoul, MD,* Anthony C. Leonard, PHD,‡
Karthikeyan Meganathan, MS,‡ Sohail Ikram, MD*
Louisville, Kentucky; and Cincinnati, Ohio
Objectives We investigated the comparative accuracy of renal translesional pressure gradients (TPG), intravascular ultrasound
(IVUS), and angiographic parameters in predicting hypertension improvement after stenting of renal artery stenosis (RAS).
Background The degree of RAS that justifies stenting is unknown.
Methods In 62 patients with RAS, TPG (resting and hyperemic systolic gradient [HSG], fractional flow reserve, and mean
gradient) were measured by a pressure guidewire; IVUS and angiographic parameters (minimum lumen area
and diameter, area stenosis, and diameter stenosis) were measured by quantitative analyses.
Results The HSG had a larger area under the curve than most other parameters and an HSG 21 mm Hg had the high-
est sensitivity, specificity, and accuracy (82%, 84%, and 84%, respectively) in predicting hypertension improve-
ment after stenting of RAS. The average IVUS area stenosis was markedly greater in RAS with an HSG 21 mm
Hg versus 21 mm Hg (78% vs. 38%, respectively; p  0.001). After stenting, hypertension improved in 84% of
patients with an HSG 21 mm Hg (n  36) versus 36% of patients with an HSG 21 mm Hg (n  26) at 12
months, p  0.01; the number of antihypertensive medications was significantly lower in patients with an HSG
21 mm Hg versus 21 mm Hg (2.30  0.90 vs. 3.40  0.50, respectively; p  0.01). By multivariable analy-
sis, HSG was the only independent predictor of hypertension improvement (odds ratio: 1.39; 95% confidence
interval: 1.05 to 1.65; p  0.013).
Conclusions An HSG 21 mm Hg provided the highest accuracy in predicting hypertension improvement after stenting of
RAS, suggesting that an HSG 21 mm Hg is indicative of significant RAS. (J Am Coll Cardiol 2009;53:
2363–71) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.03.031v
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She discordance between high procedure success and mod-
rate clinical response rates in patients with renal artery
tenosis (RAS) may stem from the limitations of angiogra-
hy for assessment of the significance of RAS. A number of
eries (1–4) demonstrated poor correlations comparing
iameter stenosis by quantitative renal angiography with a
umber of the renal translesional pressure gradients (TPG),
ncluding resting systolic gradient (RSG), fractional flow
eserve (FFR), hyperemic systolic gradient (HSG), and
yperemic mean gradient (HMG).
ontinuing Medical Education (CME) is available for this article. From the
Division of Cardiology, University of Louisville, Louisville, Kentucky; †Jewish
ospital Heart and Lung Institute, Louisville, Kentucky; and the ‡Department of
ublic Health Sciences, University of Cincinnati, Cincinnati, Ohio.6
Manuscript received December 1, 2008; revised manuscript received February 17,
009, accepted March 3, 2009.Both intravascular ultrasound (IVUS) and FFR are well-
alidated techniques for assessing the significance of a
oronary artery stenosis (5–7). Recently, it was reported that
enal FFR is a promising tool to identify hypertensive
atients with RAS who would likely benefit from renal
rtery stenting (4). However, to date, no comparative studies
f renal TPG, IVUS, and angiographic parameters have been
eported to demonstrate which parameter(s) reliably predict
ypertension improvement after stenting of RAS.
Accordingly, the objective of the present study was to
ompare the diagnostic accuracy of renal TPG, IVUS, and
ngiographic parameters in predicting hypertension im-
rovement after stenting of RAS.
ethods
tudy population. From December 2004 to August 2006,
2 patients with hypertension and unilateral RAS (50% to
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Pressure Gradients, IVUS, and Angiography for Renal Artery Stenosis June 23, 2009:2363–7190% diameter stenosis by visual
estimation) underwent assess-
ment of atherosclerotic ostial
RAS at our center. Exclusion
criteria were severe renal dys-
function as evidenced by serum
creatinine 3.0 mg/dl or kidney
length 8.0 cm, and presence of
accessory renal arteries. The in-
stitutional review board approved
the protocol and all patients gave
written informed consent.
Blood pressure and renal func-
tion measurements. Blood pres-
sure was measured according to
guidelines published by the Joint
National Committee on Preven-
tion, Detection, Evaluation, and
Treatment of High Blood Pres-
sure VII (8). Blood pressure was
obtained from patients seated in
a chair after at least 5 min of rest;
it was measured twice, and the
average of the 2 blood pressure
values was recorded. Hyperten-
ion was defined as systolic blood pressure 140 mm Hg
nd/or diastolic blood pressure 90 mm Hg. Patients with
ccelerated or refractory hypertension on 2 or 3 antihy-
ertensive medications, respectively, were enrolled into
he study. Improvement in hypertension was defined as
iastolic blood pressure 90 mm Hg and/or systolic
lood pressure 140 mm Hg or a reduction in diastolic
lood pressure by at least 15 mm Hg with the same or
educed number of antihypertensive medications. These
efinitions are in accordance with guidelines for report-
ng of renal artery revascularization in clinical trials (9).
Before discharge, antihypertensive medications were ad-
usted according to the following algorithm: the first-line
herapy included an angiotensin-converting enzyme inhib-
tor, angiotensin receptor blocker alone, or combined with a
hiazide diuretic; the second-line therapy included long-
cting calcium antagonists, beta-blockers, alpha-blockers,
ombined alpha- and beta-blockers, and hydralazine. Pa-
ients were followed by the investigators 3, 6, and 12
onths after the procedure. At each visit, in addition to
lood tests, blood pressure was measured and surveillance of
ntihypertensive medications was performed. If blood pres-
ure was not at the goal, the doses of antihypertensive
edications from the first-line therapy were increased or an
ntihypertensive agent from the second-line therapy was
dded and then recommendations were made to treating
hysicians to titrate the doses of antihypertensive medica-
ions or to add another antihypertensive agent from the
econd-line therapy to achieve the target blood pressure of
140/190 mm Hg in patients without comorbidities and
Abbreviations
and Acronyms
AUC  area under the
curve
FFR  fractional flow
reserve
HMG  hyperemic mean
gradient
HSG  hyperemic systolic
gradient
IVUS  intravascular
ultrasound
MLA  minimum lumen
area
MLD  minimum lumen
diameter
RAS  renal artery
stenosis
ROC  receiver-operating
characteristic
RSG  resting systolic
gradient
TPG  translesional
pressure gradients130/80 mm Hg in patients with diabetes and/or kidney misease, as recommended by the Joint National Committee
II guidelines (8).
xperimental protocol. After renal angiography, a 0.014-
nch pressure guidewire (RADI Medical Systems, Uppsala,
weden) was advanced into the renal artery through the
uiding catheter. After equalization of pressures, the pres-
ure transducer was advanced through the stenosis and RSG
as measured. Next, a 30-mg bolus dose of papaverine was
dministered directly into the renal artery to induce hyper-
mia, as previously reported (2–4). After papaverine injec-
ion, the guiding catheter was retracted from the ostium of
he renal artery to prevent dampening of pressures, and then
SG, FFR, and HMG were measured.
After obtaining pressure measurements, an IVUS cath-
ter (Atlantis SR Pro, Boston Scientific, Natick, Massa-
husetts) was advanced into the renal artery over pressure
uidewire. Ultrasound images were recorded after initia-
ion of automated pullback at a speed of 0.5 mm/s,
tarting approximately 10 mm distal to the lesion. A
uperVHS videotape was used to record all studies for
ffline analysis.
All patients underwent renal pressure measurements and
n IVUS procedure. After performing IVUS, all patients
nderwent renal artery angioplasty followed by stenting
sing the standard technique. Inclusion of patients for the
tudy was based on the visual estimation of stenosis (RAS
ith a diameter stenosis of 50% to 90%). Stent size was
etermined by IVUS media-to-media diameter measured at
normal-looking segment distal to post-stenotic dilation;
tent length was also determined by IVUS. Embolic pro-
ection devices were not used in any of patients. Angio-
raphic success was defined as a 30% residual stenosis
fter stenting (9).
VUS analysis. All IVUS images were analyzed off-line by
n analyst blinded to the pressure measurements using
omputerized planimetry (TapeMeasure, INDEC Systems,
ountain View, California), according to previously vali-
ated and published protocols (3,12,18).
uantitative renal angiography. Quantitative renal an-
iography was performed off-line by a skilled analyst
linded to the results of IVUS and pressure measure-
ents using validated, automated, edge-detection soft-
are (QCA-CMS 5.2 system, Medis Medical Imaging
ystems, Raleigh, North Carolina), according to previ-
usly validated and published protocols (3,6,10,11). A
epresentative example of quantitative renal angiography,
VUS analysis, and renal pressure measurements is shown
n Figure 1.
tatistical analysis. Continuous variables were analyzed
sing paired or unpaired Student t tests; categorical
ariables were compared using the chi-square test. A
eceiver-operating characteristic (ROC) analysis was per-
ormed to determine the optimal cutoff values of TPG,
VUS parameters, and angiographic parameters (as con-
inuous variables) in predicting hypertension improve-
ent (as a dichotomous variable) at 12 months. The
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June 23, 2009:2363–71 Pressure Gradients, IVUS, and Angiography for Renal Artery Stenosisut-points selected were those that yielded the greatest
um of sensitivity and specificity. The area under the
urves (AUCs) resulting from ROC analyses were com-
ared using the method suggested by DeLong et al. (12).
nivariate predictors of hypertension improvement with
values of 0.05 were entered simultaneously into a
ultivariable logistic model. Logistic regression results
re presented as odds ratio with 95% confidence intervals.
eans are presented with  SD. A probability value
0.05 (2-sided) was considered statistically significant.
esults
aseline characteristics of 62 patients are summarized in Table
. The angiographic and procedural success rates were 100%.
fter stenting, 2 patients developed femoral artery pseudoan-
Figure 1 A Representative Example of Quantitative Renal Angi
IVUS Analysis, and TPG Is Shown in a Study Patient W
The reference diameter (RD) and reference lumen area (RLA) from the reference segm
the stenotic segment (A) were selected for both quantitative angiographic and intrava
Quantitative renal angiography demonstrates that the diameter stenosis (DS) of the re
and 31 mm Hg, respectively, and both are indicative of significant renal artery stenosi
resting systolic gradient; TPG  translesional pressure gradient.urysm, which was treated by direct thrombin injection. predictors of blood pressure improvement after stenting
f RAS. The ROC analyses of parameters, including renal
PG (RSG, HSG, FFR, and HMG), IVUS parameters
MLA, MLD, area stenosis, and plaque plus media area),
ngiographic parameters (MLD and diameter stenosis), and
linical parameters (systolic, diastolic, and mean blood
ressure) are shown in Table 2. HSG measured by the
ressure guidewire had a larger AUC than most of the other
arameters by the ROC analysis in predicting hypertension
mprovement at 12 months (Table 2, Figs. 2A to 2D). The
UC for HSG was significantly greater than the AUCs for
arameters such as MLD and plaque plus media by IVUS;
LD and diameter stenosis by angiography; and systolic,
iastolic, and mean blood pressure in predicting hyperten-
ion improvement at 12 months, p  0.05 (Table 2). In
ddition, the AUCs for FFR and MLA by IVUS were
ignificantly greater than the AUCs for MLD by angiogra-
hy,
AS
) as well as minimum lumen diameter (MLD) and minimum lumen area (MLA) from
ultrasound (IVUS) analyses. Panel B is the segment with post-stenotic dilation.
ery is 57%. IVUS area stenosis (AS) and hyperemic systolic gradient (HSG) are 72%
). FFR  fractional flow reserve; LA  lumen area; LD  lumen diameter; RSG ograp
ith R
ent (C
scular
nal art
s (RAShy, systolic, diastolic, and mean blood pressure in predict-
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Pressure Gradients, IVUS, and Angiography for Renal Artery Stenosis June 23, 2009:2363–71ng hypertension improvement at 12 months, p  0.05
Table 2).
Furthermore, of the HSG values, an HSG 21 mm Hg
rovided the highest sum of sensitivity and specificity
sensitivity 82%, specificity 84%) and the highest accuracy
aseline Clinical, Angiographic, IVUS,nd Hemody amic Characteristics of Patients
Table 1 Baseline Clinical, Angiographic, IVUS,and Hemodynamic Characteristics of Patients
Patients (n  62)
Age, yrs 62 10
Diabetes mellitus, % 17
Coronary artery disease, % 48
Smoking, % 28
Hyperlipidemia, % 86
Systolic blood pressure, mm Hg 170 12
Diastolic blood pressure, mm Hg 91 13
Serum creatinine levels, mg/dl 1.20 0.33
Quantitative angiographic parameters
MLD, mm 2.38 0.70
Reference lumen diameter, mm 6.10 0.72
Diameter stenosis, % 61 10
Quantitative IVUS parameters
MLD, mm 2.73 1.01
MLA, mm2 8.91 5.37
Area stenosis, % 69 24
Plaque plus media area, mm2 14.29 8.78
Hemodynamic parameters
RSG, mm Hg 16 14
HSG, mm Hg 28 22*
FFR 0.89 0.09
HMG, mm Hg 10 9.0
nless otherwise indicated, data are presented as mean  SD. *p  0.05 versus resting systolic
radient.
FFR  fractional flow reserve; HMG  hyperemic mean gradient; HSG  hyperemic systolic
radient; IVUS  intravascular ultrasound; MLA minimum lumen area; MLD minimum lumen
iameter; RSG  resting systolic gradient.
eceiver-Operating Characteristic Analyses of the Optimal Cutpoinf Parameters in Predicting Hyperte sion Improv ment After Stent
Table 2 Receiver-Operating Characteristic Analyses of the Optiof Parameters in Predicting Hypertension Improvement
Parameters AUC 95% Confidence Interval
Renal pressure measurements
HSG 0.87 0.72–0.96
FFR 0.85 0.76–0.94
HMG 0.81 0.70–0.91
RSG 0.81 0.71–0.92
IVUS parameters
MLA 0.86 0.76–0.95
Area stenosis 0.82 0.71–0.92
MLD 0.78 0.67–0.90
Plaque plus media area 0.73 0.60–0.85
Angiographic parameters
Diameter stenosis 0.74 0.61–0.86
MLD 0.69 0.55–0.82
Clinical parameters
Systolic blood pressure 0.55 0.41–0.70
Diastolic blood pressure 0.51 0.36–0.66
Mean blood pressure 0.54 0.39–0.68p  0.05 versus HSG, †p  0.05 versus MLA and FFR.
AUC  area under the curve; RAS  renal artery stenosis; other abbreviations as in Table 1.84%) in predicting hypertension improvement after stent-
ng of RAS (Table 2). Likewise, in order to identify the
ndependent predictors of hypertension improvement, we
rst assessed the parameters individually, as shown in Table 3.
n the univariate model, renal TPG (RSG, HSG, FFR, and
MG); IVUS parameters (MLA, MLD, area stenosis, and
laque plus media area); and MLD by angiography were
ignificantly associated with hypertension improvement
Table 3). When the above-mentioned parameters were
laced simultaneously in a multivariable logistic model,
SG was the only parameter that predicted blood pressure
mprovement independent of the other predictors in the
odel (odds ratio: 1.32; 95% confidence interval: 1.05 to
.65; p  0.013).
omparative data of IVUS, angiographic, and hemody-
amic parameters. Having shown that an HSG 21 mm
g provided the highest accuracy in predicting hypertension
mprovement, we next compared IVUS, angiographic, and
emodynamic parameters among patients with an HSG 21
m Hg versus an HSG 21 mm Hg (Table 4). HSG was
21 mm Hg in 36 patients with RAS (58%); HSG was 21
m Hg in 26 patients (42%). IVUS MLA and IVUS MLD
ere significantly smaller, but IVUS area stenosis and IVUS
laque plus media area were significantly greater in patients
ith an HSG21 mm Hg versus an HSG21 mm Hg. Of
he angiographic parameters, only MLD was significantly
maller in patients with an HSG21 mm Hg versus an HSG
21 mm Hg. RSG and HMG were significantly higher, but
FR was significantly lower in patients with an HSG21 mm
g versus an HSG 21 mm Hg.
linical outcome. There has been significant variability in
he association of the preceding parameters in predicting
ajor adverse outcomes such as death, myocardial infarc-
RAS
utpoints
r Stenting of RAS
point Sensitivity, % Specificity, % Predictive Accuracy, %
m Hg 82 84 84
.90 73 88 79
m Hg 80 76 79
m Hg 78 76 77
m2 78 80 79
% 75 80 77
m 70 76 72*
m2 73 68 70*
% 68 72 69*
m 51 80 62*†
m Hg 43 68 53*†
m Hg 41 64 50*†
m Hg 51 60 54*†tsing of
mal C
Afte
Cut
21 m
0
6.0 m
7.0 m
7.8 m
67
2.7 m
9.0 m
60
2.25 m
170 m
95 m
118 m
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June 23, 2009:2363–71 Pressure Gradients, IVUS, and Angiography for Renal Artery Stenosision, stroke, or progression of renal insufficiency; thus, the
linical outcome of the present study is limited to the
ncidence of death, hypertension improvement, and serum
reatinine levels at follow-up. During the 12-month
ollow-up period, no patient died or was otherwise lost to
ollow-up; 3 patients (1 patient with an HSG 21 mm Hg
nd 2 patients with an HSG 21 mm Hg) developed
ccelerated hypertension and underwent repeat renal an-
iography to assess for possible in-stent restenosis. Angiog-
aphy demonstrated minimal in-stent restenosis. In these
atients, hypertension was then adequately controlled by
ncreasing the dose of angiotensin-converting enzyme in-
ibitors and thiazides.
After stenting, systolic and diastolic blood pressures, at
-, 6-, and 12-month follow-up, were significantly lower in
atients with an HSG 21 mm Hg (n  36) than in those
ith an HSG 21 mm Hg (n 26) (Figs. 3A and 3B). At
- and 6-month follow-up, 89% and 86% of patients who
ad an HSG 21 mm Hg met the criteria for hypertension
Figure 2 Receiver-Operating Characteristic Curves of HSG, FFR
The ROC curve for (A) HSG; (B) FFR; (C) IVUS area stenosis (AS); and (D) diamet
by quantitative angiography (QRA DS). ROC  receiver-operating characteristic; othmprovement compared with 38% and 42% of patients in thom HSG was 21 mm Hg, respectively; p  0.01 (Fig.
C). At 12 months, hypertension improvement was sus-
ained in 84% of patients with an HSG 21 mm Hg (n 
6) compared with 36% of patients with an HSG 21 mm
g (n  26); p  0.01 (Fig. 3C).
Before stenting, the number of antihypertensive medica-
ions was not significantly different between the groups
3.03 0.69 vs. 2.92 0.42). After stenting, the number of
ntihypertensive medications at 6- and 12-month follow-up
as significantly lower in patients with an HSG 21 mm
g than in those with an HSG 21 mm Hg (2.30  0.54
s. 3.40  0.50 and 2.30  90 vs. 3.40  0.50, respectively;
 0.01) (Fig. 4A). In patients with an HSG 21 mm Hg,
he doses of antihypertensive medications were either signifi-
antly lower or remained unchanged compared with baseline at
2-month follow-up (Table 5). In contrast, among patients
ith an HSG 21 mm Hg, doses of the majority of antihy-
ertensive medications were significantly higher compared
ith baseline at 12-month follow-up (Table 5). Furthermore,
S, and Diameter Stenosis for Hypertension Improvement
osis
reviations as in Figure 1., IVU
er sten
er abbhe doses of the majority of antihypertensive medications were
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Pressure Gradients, IVUS, and Angiography for Renal Artery Stenosis June 23, 2009:2363–71ignificantly lower in patients with an HSG 21 mm Hg
ompared with those with an HSG21 mm Hg at 12-month
ollow-up (Table 5).
Serum creatinine levels were not significantly different at
aseline, at 6-, and 12-month follow-up between the groups
1.22  0.45 mg/dl vs. 1.15  0.40 mg/dl, 1.18  0.45
g/dl vs. 1.10  0.25 mg/dl, and 1.05  0.30 mg/dl vs.
.15  0.35 mg/dl) (Fig. 4B).
iscussion
o the best of our knowledge, the present study is the
rst prospective study to compare the diagnostic accuracy
f renal TPG, IVUS, and quantitative renal angiography
n predicting hypertension improvement after stenting of
AS. Our data demonstrated that an HSG 21 mm Hg
easured by pressure guidewire is the strongest predictor
f hypertension improvement after stenting of RAS,
uggesting that an HSG 21 mm Hg is indicative of
emodynamically significant RAS. In contrast, diameter
Univariate Predictors of HypertensionImprovement After Stenting of RAS at 12 Month
Table 3 Univariate Predictors of HypertensioImprovement After Stenting of RAS
Predictors
HSG, mm Hg
IVUS MLA, mm2
IVUS area stenosis, %
IVUS MLD, mm
IVUS plaque plus media area, mm2
FFR
HMG, mm Hg
RSG, mm Hg
MLD by quantitative renal angiography, mm
Diameter stenosis by quantitative renal angiography, %
Baseline systolic blood pressure, mm Hg
Baseline diastolic blood pressure, mm Hg
Baseline mean blood pressure, mm Hg
RAS  renal artery stenosis; other abbreviations as in Table 1.
Mean Values of IVUS, Angiographic, and HemodynPar meters in Patients With an HSG >21 m Hg
Table 4 Mean Values of IVUS, Angiographic, aParameters in Patients With an HSG
Parameters HSG >21 mm
IVUS parameters
MLA, mm2 5.0
MLD, mm 2.11
Area stenosis, % 78
Plaque plus media area,mm2 19.54
Quantitative angiographic parameters
MLD, mm 2.15
Reference diameter, mm 6.12
Diameter stenosis, % 65
Hemodynamic parameters
RSG, mm Hg 25
HSG, mm Hg 42
FFR 0.84Unless otherwise indicated, data are presented as mean SD.
Abbreviations as in Table 1.tenosis measured by quantitative renal angiography did
ot predict blood pressure improvement. At 12-month
ollow-up, blood pressure, doses, and number of antihy-
ertensive medications were significantly lower in pa-
ients with an HSG 21 mm Hg than in those with an
SG 21 mm Hg.
ssessment of renal artery stenosis. Guidelines for renal
rtery revascularization (13) suggested that a significant
AS is defined as the presence of 50% to 70% diameter
tenosis by visual estimation, with a peak translesional
radient of at least 20 mm Hg, or a mean gradient of at
east 10 mm Hg measured with a 5-F catheter or
ressure guidewire. However, the use of a 4- or 5-F
atheter would overestimate the pressure gradient. In this
espect, Colyer et al. (1) reported that a 4-F catheter
ignificantly overestimated the severity of RAS because a
.014-inch pressure guidewire compared with a 4-F
atheter would occupy 6% versus 24% of the renal artery,
espectively.
2 Months
ds Ratio 95% Confidence Interval p Value
1.12 1.05–1.19 0.0001
0.78 0.68–0.89 0.0003
1.04 1.02–1.07 0.0005
0.62 0.12–0.57 0.0008
1.12 1.03–1.21 0.0047
0.79 0.69–0.90 0.0007
1.22 1.06–1.41 0.0045
1.09 1.02–1.17 0.0068
0.39 0.17–0.92 0.03
1.02 0.95–1.09 0.48
1.01 0.97–1.05 0.49
0.97 0.93–1.01 0.11
0.98 0.93–1.02 0.40
us <21 mm Hg
emodynamic
mm Hg Versus <21 mm Hg
 36) HSG <21 mm Hg (n  26) p Value
13.72 3.32 0.001
3.50 0.79 0.001
38 16 0.001
8.17 4.83 0.001
2.77 0.72 0.01
5.95 0.74 0.45
54 8.0 0.33
3.62 3.92 0.001
9.6 4.0 0.001
0.96 0.03 0.001s
n
at 1
OdamicVers
nd H
>21
Hg (n
 1.86
 0.47
 10
 7.42
 0.50
 0.65
 7.0
 20
 19
 0.09
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June 23, 2009:2363–71 Pressure Gradients, IVUS, and Angiography for Renal Artery StenosisIn the coronary circulation, maximal hyperemia is essen-
ial in determining the physiological significance of stenoses
etected by angiography. Likewise, it has been demon-
trated that a vasodilator reserve exists in the renal circula-
ion. By analogy, it is conceivable to induce hyperemic
radient by vasoactive agents to assess the significance of
AS. In this respect, Beregi et al. (14) showed that
ntrarenal injection of isosorbide dinitrate or papaverine
ignificantly increased renal blood flow in pigs, but the
yperemia was significantly greater with papaverine com-
ared with isosorbide dinitrate because papaverine dilates
mall resistance vessels; isosorbide dinitrate dilates only
picardial vessels. In the present study, the use of papaverine
Figure 3
Systolic and Diastolic Blood Pressure at
Baseline and Follow-Up Among Patients With
an HSG >21 Versus <21 mm Hg
(A and B) Systolic blood pressure at baseline was significantly greater in RAS
with HSG 21 mm Hg versus an HSG 21 mm Hg. During follow-up, systolic
and diastolic blood pressures were significantly lower in RAS with an HSG 21
mm Hg versus an HSG 21 mm Hg. (C) During follow-up, an improvement in
hypertension was significantly greater in RAS with an HSG 21 mm Hg versus
an HSG 21 mm Hg. Abbreviations as in Figure 1.as based on previous studies (2–4,14–16) in which intra-enal papaverine was used extensively to either induce
yperemia or to assess the significance of RAS.
In 3 recent series, the pressure guidewire was used to
etermine the significance of RAS. Jones et al. (17) mea-
ured HSG in 22 patients with RAS; these investigators
emonstrated that, after stenting of RAS in 13 patients with
SG 20 mm Hg, systolic blood pressure significantly
mproved at follow-up. The present study has validated the
ndings of Jones et al. (17) that HSG is a significant
redictor of hypertension improvement after stenting of
AS. De Bruyne et al. (18) demonstrated a Pd/Pa ratio (the
atio of distal renal pressure to aortic pressure) of 0.90 as a
hreshold for renin release. These investigators (18) mea-
ured Pd/Pa ratio by a pressure guidewire while a balloon
atheter was inflated inside of the stented segment of renal
rtery to induce a controlled pressure gradient between the
orta and distal renal artery. They concluded that a Pd/Pa
atio 0.90 could be considered a hemodynamically signif-
cant RAS; however, this index needs to be validated with
linical outcomes. Mitchell et al. (4) reported that stenting
n 17 patients with RAS resulted in a significant hyperten-
Figure 4
Number of Antihypertensive Medications and Serum
Creatinine Levels at Baseline and Follow-Up Among
Patients With an HSG >21 Versus <21 mm Hg
(A) The numbers of antihypertensive medications were similar at baseline. Dur-
ing follow-up, the number of antihypertensive medications was significantly
lower in RAS with an HSG 21 mm Hg than with HSG 21 mm Hg. (B) Serum
creatinine levels were not significantly different between the groups either at
baseline or during follow-up. Abbreviations as in Figure 1.
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ompared with those with an FFR0.80. It is worth noting
hat Mitchell et al. (4) did not measure HSG to assess
ypertension improvement after stenting of RAS. In addi-
ion, our data demonstrated that renal FFR was not an
ndependent predictor of hypertension improvement after
tenting of RAS. Although the measurement of FFR is useful
n the coronary circulation (10), a large body of evidence
upports the low predictive power of FFR in predicting
ypertension improvement (11,15,16). An explanation is prob-
bly linked to lower vasodilator reserve in the renal circulation
han in the coronary microvasculature, and a number of
nvestigators have shown renal flow reserve to be variable and
n some cases is very low (5,15,16).
With respect to the measurement of renin, a number of
eries (19,20) have demonstrated that renal vein renin
ctivity increases in patients with renal artery stenosis.
lthough the renal vein renin assay is possibly beneficial,
owever, the measurements are impractical to obtain.
lood pressure improvement after stenting of renal
rtery stenosis. Despite a high procedural success rate of
enal artery stenting, an improvement in hypertension has
een inconsistent. This most likely reflects the absence of
redictors for blood pressure improvement after renal artery
tenting. Rocha-Singh et al. (21) reported that stenting of
AS based on visual estimation resulted in blood pressure
mprovement in 47% of their patients at 24 months. Others
eported an improvement in blood pressure in 62% (22) and
6% of patients at 12 months (23). These studies required
ore stringent criteria before stenting, including duplex
ltrasound or evidence for a critical RAS based on quanti-
ative renal angiography. Because the correlation between
enal pressure measurements and angiographic diameter
tenosis is poor, it is likely that patients without significant
ressure gradient have been included in these trials. Such an
nconsistent blood pressure response to renal stenting un-
erscores the value of renal pressure measurements for
ppropriate patient selection. The CORAL (Cardiovascular
utcomes in Renal Atherosclerotic Lesions) trial (24)
andomized patients based on severity of angiographic
oses of Antihypertensive Medications at Baseline and After Stent
Table 5 Doses of Antihypertensive Medications at Baseline and
Medications, mg
HSG >21 mm Hg
Baseline 12 Months
Lisinopril 28 12 27 11
Valsartan 240 84 224 83
Hydrochlorothiazide 15 5.0 8.59 7.0
Amlodipine 8.91 4.8 5.21 4.8
Metoprolol 88 22 80 32
Clonidine 0.68 0.10 0.21 0.30
Labetalol 571 75 455 222
Hydralazine 192 73 114 80
nless otherwise indicated, data are presented as mean  SD. *p  0.05, comparing the group
HSG  hyperemic systolic gradient.tenosis. These data suggest that hemodynamic significances much more important than angiographic severity. As
uch, stenting of hemodynamically nonsignificant lesions in
he CORAL trial is unlikely to confer any benefit compared
ith medical therapy. Instead, it may be more useful to
ompare repair of hemodynamically significant lesions with
edical therapy. In particular, in light of the observed
9.7% major adverse event rate that has been reported after
enal artery stenting (21), HSG-guided renal artery stenting
llows for better selection of patients who may benefit from
enal artery stenting. The limitation of our study is inherent
o small sample size; a large randomized trial comparing
utcomes among HSG-guided stenting versus medical
herapy is warranted.
onclusions
n this first report of the comparative accuracy of the renal
PG, IVUS, and angiography in patients with RAS, we
emonstrated that in patients with RAS, an HSG 21 mm
g was an independent predictor of blood pressure im-
rovement after stenting of RAS. Our results showed that
mong patients with RAS, regardless of their angiographic
everity, an HSG21 mm Hg indicates a hemodynamically
ignificant RAS. Furthermore, in this setting, HSG can be
asily measured after renal angiography with a pressure
uidewire, circumventing the need for IVUS or renal vein
enin study to determine the significance of RAS. This
ould, in turn, facilitate decision-making regarding medical
herapy versus stenting in patients with RAS.
eprint requests and correspondence: Dr. Massoud A. Leesar, Divi-
ion of Cardiology, University of Cincinnati, 231 Albert Sabin Way,
SB-3054, Cincinnati, Ohio 45267. E-mail: leesarma@uc.edu.
EFERENCES
1. Colyer WR, Cooper CJ, Burket MW, Thomas WJ. Utility of a 0.014==
pressure-sensing guidewire to assess renal artery translesional systolic
pressure gradients. Catheter Cardiovasc Interv 2003;59:372–7.
2. Subramanian R, White CJ, Rosenfield K, et al. Renal fractional flow
t 12 Months
r Stenting at 12 Months
HSG <21 mm Hg
Value Baseline 12 Months p Value
.34 23 8.0 38 6* 0.001
.44 205 78 297 60* 0.03
.015 19.6 6.4 22.5 4.5* 0.047
.001 7.9 2.5 9.8 0.20* 0.017
.16 77 26 96 14 0.018
.004 0.62 0.17 0.60 0.10* 0.81
.23 466 103 556 82 0.076
.062 178 56 192 53* 0.71
HSG 21 mm Hg versus the group with an HSG 21 mm Hg at 12 months.ing a
Afte
p
0
0
0
0
0
0
0
0reserve: a hemodynamic evaluation of moderate renal artery stenoses.
Catheter Cardiovasc Interv 2005;64:480–6.
11
1
1
1
1
1
1
1
1
2
2
2
2
2
K
2371JACC Vol. 53, No. 25, 2009 Leesar et al.
June 23, 2009:2363–71 Pressure Gradients, IVUS, and Angiography for Renal Artery Stenosis3. Siddiqui TS, Elghoul Z, Reza ST, Leesar MA. Renal hemodynamics:
theory and practical tips. Catheter Cardiovasc Interv 2007;69:894–901.
4. Mitchell JA, Subramanian R, White CJ, et al. Predicting blood
pressure improvement in hypertensive patients after renal artery stent
placement. Catheter Cardiovasc Interv 2007;69:685–9.
5. Kern MJ, Meier B. Evaluation of the culprit plaque and the physio-
logical significance of atherosclerotic coronary narrowings. Circulation
2001;103:31–42.
6. Leesar MA, Abdul-Baki T, Akkus NI, Sharma A, Kannan T, Bolli R.
Use of fractional flow reserve versus stress perfusion scintigraphy after
unstable angina. Effect on duration of hospitalization, cost, procedural
characteristics, and clinical outcome. J Am Coll Cardiol 2003;7:
1115–21.
7. Fearon WF, Luna J, Samady H, et al. Fractional flow reserve
compared with intravascular ultrasound guidance for optimizing stent
deployment. Circulation 2001;104:1917–22.
8. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the
Joint National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure: the JNC-7 report. JAMA 2003;
289:2560–72.
9. Rundback JH, Sacks D, Kent KC, et al. Guidelines for the reporting
of renal artery revascularization in clinical trials. J Vasc Interv Radiol
2002;13:959–74.
0. Jasti V, Ivan E, Yalamanchili V, Wongpraparut N, Leesar MA.
Correlations between fractional flow reserve and intravascular ultra-
sound in patients with an ambiguous left main coronary artery stenosis.
Circulation 2004;110:2831–6.
1. Varma J, Shapira A, Ikram S, Leesar MA. Correlations between
hyperemic pressure gradient, intravascular ultrasound, Duplex ultra-
sound, and quantitative angiography in patients with renal artery
stenosis (abstr). J Am Coll Cardiol 2006;41 Suppl 2:32B.
2. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas
under two or more correlated receiver operating characteristic curves; a
nonparametric approach. Biometrics 1988;44:837–45.
3. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA guidelines for
the management of patients with peripheral arterial disease (lower
extremity, renal, mesenteric, and abdominal aortic): a collaborative
report from the American Association for Vascular Surgery/Society for
Vascular Surgery, Society for Cardiovascular Angiography and Inter-
ventions, Society of Interventional Radiology, Society for Vascular
Medicine and Biology, and the American College of Cardiology/(Writing Committee to Develop Guidelines for the Management of
Patients With Peripheral Arterial Disease). J Am Coll Cardiol
2006;47:e1–192.
4. Beregi JP, Lahoche A, Willoteaux S, et al. Renal artery vasomotion: in
vivo assessment in the pigs with intravascular Doppler. Fundam Clin
Pharmacol 1998;12:613–8.
5. Mounier-Vehier C, Cocheteux B, Haulon S, et al. Changes in renal
blood flow reserve after angioplasty of renal artery stenosis in hyper-
tensive patients. Kidney Int 2004;65:245–50.
6. Manoharan G, Pijls NH, Lameire N, et al. Assessment of renal flow
and flow reserve in humans. J Am Coll Cardiol 2006;47:620–5.
7. Jones JJ, Bates ER, Chetcuti DJ, Lederman RJ, Grossman M.
Usefulness of translesional pressure gradient and pharmacological
provocation for the assessment of intermediate renal artery disease.
Catheter Cardiovas Interv 2006;68:429–34.
8. De Bruyne B, Manoharan G, Pijls NH, et al. Assessment of renal
artery stenosis severity by pressure gradient measurements. J Am Coll
Cardiol 2006;48:1851–5.
9. Pickering TG, Sos TA, Vaughan ED, et al. Predictive value and
changes of renin secretion in hypertensive patients with unilateral
renovascular disease undergoing successful renal angioplasty. Am J
Med 1984;76:398–403.
0. Rappelli A, Glorioso N, Madeddu P, et al. Renal vein renin in
renovascular hypertension: the experience of the two Italian centers.
Nephron 1986;44:12–6.
1. Rocha-Singh K, Jaff MR, Rosenfield K. Evaluation of the safety and
effectiveness of renal artery stenting after unsuccessful balloon angio-
plasty. J Am Coll Cardiol 2005;46:776–83.
2. Blum U, Krumme B, Flugel P, et al. Treatment of ostial renal artery
stenosis with vascular endoprostheses after unsuccessful balloon angio-
plasty. N Engl J Med 1997;336:459–65.
3. Zeller T, Frank U, Muller C, et al. Predictors of improved renal
function after percutaneous stent-supported angioplasty of severe
atherosclerotic ostial renal artery stenosis. Circulation 2003;108:
2244–9.
4. Cooper CJ, Murphy TP, Matsumoto A, et al. Stent revascularization
for the prevention of cardiovascular and renal events among patients
with renal artery stenosis and systolic hypertension: rationale and
design of the CORAL trial. Am Heart J 2006;152:59–66.
ey Words: renal artery stenosis y renal translesional pressure gradients
American Heart Association Task Force on Practice Guidelines y intravascular ultrasound y angiography.
Go to http://cme.jaccjournals.org
to take the CME quiz for this article.
